Day One Biopharmaceuticals Inc

DAWN

Get informed when a big investor buys or sells

Market Cap$2.22B

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Day One Biopharmaceuticals Inc	-20.7	-	-24%	21.5	-

$21.50

Target Price by Analysts

0.1% downsideDay One Biopharmaceuticals Target Price Details

$22.93

Current Fair Value

6.5% upside

Undervalued by 6.5% based on the discounted cash flow analysis.

Share Statistics

Market cap	$2.22 Billion
Enterprise Value	$2.03 Billion
Dividend Yield	$- (-)
Earnings per Share	$-1.04
Beta	-1.75
Outstanding Shares	103,381,315

Return

Return on Equity	-24.33%
Return on Assets	-21.13%
Return on Invested Capital	-26.82%

Valuation & Multiples

P/E Ratio	-20.7
PEG	30.61
Price to Sales	21.53
Price to Book Ratio	5.38
Enterprise Value to Revenue	12.85
Enterprise Value to EBIT	-16.94
Enterprise Value to Net Income	-19
Total Debt to Enterprise	0
Debt to Equity	0.01

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

May 13, 2026

EPS Estimate

$-0.28

Average shareholder expectation

Revenue Estimate

$55.10 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	1.0621▲ 18.39%
Total Calls	804,000▲ 24.59%
Total Puts	853,900▲ 50.68%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	83.98%▲ 5.24%
Total Invested	$1.85B▲ 143.49%
Investors Holding	219▲ 20.00%

ESG Score